Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Otologic Pharmaceutics | Therapeutic Solutions for Hearing |
Description | OtologicPharmaceutics Home Our programs and science Press and Media Hearing Loss Pipeline Contact Us Selected Publications Otologic Pharmaceutics Therapeutic Solutions for Hear |
Keywords | N/A |
WebSite | otologicpharma.com |
Host IP | 69.16.232.183 |
Location | United States |
Site | Rank |
US$2,579,061
Last updated: 2023-05-11 20:52:34
otologicpharma.com has Semrush global rank of 4,103,938. otologicpharma.com has an estimated worth of US$ 2,579,061, based on its estimated Ads revenue. otologicpharma.com receives approximately 297,584 unique visitors each day. Its web server is located in United States, with IP address 69.16.232.183. According to SiteAdvisor, otologicpharma.com is safe to visit. |
Purchase/Sale Value | US$2,579,061 |
Daily Ads Revenue | US$2,381 |
Monthly Ads Revenue | US$71,421 |
Yearly Ads Revenue | US$857,042 |
Daily Unique Visitors | 19,839 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
otologicpharma.com. | A | 599 | IP: 69.16.232.183 |
otologicpharma.com. | NS | 3600 | NS Record: ns35.domaincontrol.com. |
otologicpharma.com. | NS | 3600 | NS Record: ns36.domaincontrol.com. |
otologicpharma.com. | MX | 3600 | MX Record: 0 west.smtp.mx.exch082.serverdata.net. |
otologicpharma.com. | MX | 3600 | MX Record: 10 east.smtp.mx.exch082.serverdata.net. |
otologicpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.intermedia.net ~all |
Home Our programs and science Press and Media Hearing Loss Pipeline Contact Us Selected Publications Otologic Pharmaceutics Therapeutic Solutions for Hearing Health About Hearing Loss Latest Press & Media 2020 – 2021 Updates from Otologic Pharaceutics Articles about us: Oblato Acquires Rights to Hearing Loss Drug (https://hearingreview.com/inside-hearing/research/hei)Bringing Back Silence (https://houghear.org/bringing-back-silence/) Noteworthy News: Our President, Dr. Elaine Hamm, was an invited speaker to the... read more All Press & Media Our mission Otologic Pharmaceutics, Inc. (OPI) is a company committed to developing treatments for acute and chronic hearing loss to reduce the incidence and severity of permanent hearing disorders. Learn More Our mission is to treat hearing loss. Otologic Pharmaceutics, Inc. (OPI) is a company committed to developing treatments for acute and chronic hearing loss to reduce the incidence and severity of permanent hearing disorders. OPI’s program |
HTTP/1.1 302 Found Date: Sun, 14 Nov 2021 09:02:35 GMT Server: Apache Location: http://otologicpharma.com/cgi-sys/suspendedpage.cgi Cache-Control: max-age=600 Expires: Sun, 14 Nov 2021 09:12:35 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sun, 14 Nov 2021 09:02:35 GMT Server: Apache Cache-Control: max-age=600 Expires: Sun, 14 Nov 2021 09:12:35 GMT Vary: Accept-Encoding,User-Agent Content-Type: text/html |
Domain Name: OTOLOGICPHARMA.COM Registry Domain ID: 2277448796_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-06-20T19:31:33Z Creation Date: 2018-06-20T19:31:32Z Registry Expiry Date: 2023-06-20T19:31:32Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS35.DOMAINCONTROL.COM Name Server: NS36.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-14T07:53:41Z <<< |